Editorial: The roles of ion-induced cell death in cancer treatment: volume II

Frontiers in Pharmacology

Pharmacology

Zhijie Xu¹  Zhi-Yao He²  Isha Gaurav³  Zhijun Yang⁴  Kui Zhang⁵  Xin Hu⁵  Abhimanyu Thakur⁶  Guangzhao Pan⁷ 

[1] Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China;Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, Sichuan, China;School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China;School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China;Changshu Research Institute, Hong Kong Baptist University, Changshu Economic and Technological Development (CETD) Zone, Changshu, China;State Key Laboratory of Resource Insects, Medical Research Institute, Southwest University, Chongqing, China;The Pritzker School of Molecular Engineering, Ben May Department for Cancer Research, University of Chicago, Chicago, IL, United States;Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China;Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou, Zhejiang, China;

关键词: ion homeostasis;    cell death;    ferroptosis;    cuproptosis;    PANoptosis;    cancer;   

DOI  :  10.3389/fphar.2023.1289829

 received in 2023-09-06, accepted in 2023-09-11,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Zhang, He, Thakur, Hu, Gaurav, Yang, Xu and Pan.